Total Payments
$19,047
2024 Payments
$1,982
Companies
54
Transactions
1,327
Medicare Patients
16,797
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$18,383 (96.5%)
Other$625.00 (3.3%)
Education$24.30 (0.1%)
Consulting$15.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,383 | 1,321 | 96.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $625.00 | 1 | 3.3% |
| Education | $24.30 | 4 | 0.1% |
| Consulting Fee | $15.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,153 | 145 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,840 | 129 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,789 | 82 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,231 | 133 | $0 (2023) |
| Boston Scientific Corporation | $1,185 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,078 | 74 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $976.59 | 141 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $855.44 | 43 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $838.31 | 73 | $0 (2023) |
| Amarin Pharma Inc. | $836.55 | 58 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,982 | 113 | Amgen Inc. ($248.86) |
| 2023 | $2,518 | 154 | Boston Scientific Corporation ($314.06) |
| 2022 | $2,391 | 163 | Novartis Pharmaceuticals Corporation ($386.25) |
| 2021 | $2,315 | 187 | Amgen Inc. ($296.32) |
| 2020 | $1,867 | 134 | Amgen Inc. ($254.42) |
| 2019 | $2,456 | 221 | Janssen Pharmaceuticals, Inc ($304.44) |
| 2018 | $2,807 | 180 | SANOFI-AVENTIS U.S. LLC ($834.23) |
| 2017 | $2,713 | 175 | Novartis Pharmaceuticals Corporation ($410.68) |
All Payment Transactions
1,327 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.64 | General |
| Category: Cardiology | ||||||
| 12/24/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: Cardiology | ||||||
| 12/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $32.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Cardiology | ||||||
| 11/27/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.72 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Obesity | ||||||
| 11/01/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $22.93 | General |
| Category: Cardiovascular Device | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.07 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: Coronary | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.08 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 4,848 | 6,238 | $1.2M | $321,060 |
| 2022 | 17 | 4,091 | 5,252 | $1.1M | $282,671 |
| 2021 | 23 | 4,001 | 5,135 | $1.1M | $304,754 |
| 2020 | 22 | 3,857 | 4,963 | $1.0M | $245,074 |
Total Patients
16,797
Total Services
21,588
Medicare Billing
$1.2M
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,033 | 1,652 | $600,616 | $160,917 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 530 | 586 | $144,859 | $40,396 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 124 | 179 | $87,581 | $26,078 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 265 | $63,600 | $17,855 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $63,365 | $14,439 | 22.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,469 | 1,898 | $75,892 | $12,867 | 17.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 746 | 813 | $47,967 | $9,623 | 20.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 89 | $30,527 | $8,963 | 29.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 141 | 141 | $34,122 | $7,684 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $23,494 | $6,138 | 26.1% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 27 | 27 | $21,600 | $4,796 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $14,924 | $3,503 | 23.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 53 | 55 | $13,310 | $3,194 | 24.0% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 83 | 85 | $7,565 | $1,739 | 23.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 101 | 101 | $4,949 | $1,017 | 20.6% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 87 | 89 | $4,895 | $948.36 | 19.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 38 | 39 | $1,638 | $389.84 | 23.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 12 | 14 | $1,190 | $294.98 | 24.8% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 15 | 15 | $1,335 | $218.68 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 923 | 1,541 | $559,383 | $151,940 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 485 | 531 | $131,157 | $36,488 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 98 | 118 | $57,466 | $18,397 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 141 | 141 | $77,691 | $17,407 | 22.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 105 | 202 | $48,000 | $11,771 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 746 | 793 | $46,787 | $8,891 | 19.0% |
About Dr. John Cosmi, MD
Dr. John Cosmi, MD is a Interventional Cardiology healthcare provider based in Morristown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558458950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Cosmi, MD has received a total of $19,047 in payments from pharmaceutical and medical device companies, with $1,982 received in 2024. These payments were reported across 1,327 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($18,383).
As a Medicare-enrolled provider, Cosmi has provided services to 16,797 Medicare beneficiaries, totaling 21,588 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Morristown, NJ
- Active Since 10/06/2006
- Last Updated 02/03/2016
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1558458950
Products in Payments
- Repatha (Biological) $1,513
- MULTAQ (Drug) $1,465
- ENTRESTO (Drug) $1,395
- XARELTO (Drug) $1,216
- ELIQUIS (Drug) $932.22
- LifeVest (Device) $855.44
- Vascepa (Drug) $836.55
- Corlanor (Drug) $590.42
- JARDIANCE (Drug) $555.03
- PRADAXA (Drug) $523.01
- Edarbyclor (Drug) $495.49
- Livalo (Drug) $473.90
- Edarbi (Drug) $473.43
- VERQUVO (Drug) $468.26
- LEQVIO (Drug) $444.99
- WATCHMAN Access System (Device) $444.71
- WATCHMAN (Device) $428.70
- PRALUENT (Drug) $324.21
- FARXIGA (Drug) $302.77
- WATCHMAN FLX (Device) $276.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Morristown
Sunil Ramaprasad, M.d., F.a.c.c, M.D., F.A.C.C
Interventional Cardiology — Payments: $165,544
Interventional Cardiology $165,544
Mark Blum, Md, MD
Interventional Cardiology — Payments: $90,620
Interventional Cardiology $90,620
Amirali Masoumi, M.d, M.D
Interventional Cardiology — Payments: $44,030
Interventional Cardiology $44,030
Craig Rosen, Md, MD
Interventional Cardiology — Payments: $28,337
Interventional Cardiology $28,337
Dr. Nazir Savji, Md, MD
Interventional Cardiology — Payments: $27,223
Interventional Cardiology $27,223
Dr. Leonid Mandel, M.d, M.D
Interventional Cardiology — Payments: $18,503
Interventional Cardiology $18,503